Kezar Life Sciences, Inc. - Common Stock (KZR)
CUSIP: 49372L209
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 7,437,095
- Total 13F shares
- 4,474,800
- Share change
- +145,561
- Total reported value
- $20,493,118
- Price per share
- $4.58
- Number of holders
- 38
- Value change
- +$639,707
- Number of buys
- 12
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 49372L209?
CUSIP 49372L209 identifies KZR - Kezar Life Sciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 49372L209:
Top shareholders of KZR - Kezar Life Sciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.7%
|
720,000
|
$3,513,600 | — | 31 Mar 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
9.6%
|
716,759
|
$3,497,784 | — | 31 Mar 2025 | |
| Avidity Partners Management LP |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
502,600
|
$2,452,688 | — | 31 Mar 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
5.5%
|
408,138
|
$1,991,713 | — | 31 Mar 2025 | |
| Morningside Venture Investments Ltd |
3/4/5
13D/G
|
10%+ Owner · Morningside Venture Investments Limited |
—
class O/S missing
|
1,947,993
|
$1,753,194 | — | 15 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
276,228
|
$1,347,993 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.6%
|
192,700
|
$940,376 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2%
|
147,404
|
$719,332 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.8%
|
133,525
|
$650,000 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
1.7%
|
124,427
|
$607,204 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.5%
|
108,473
|
$529,348 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
106,901
|
$521,677 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.3%
|
100,000
|
$488,000 | — | 31 Mar 2025 | |
| Equal Talent Investments Ltd |
13D/G
|
Equal Talent Investments Limited |
8.7%
|
616,502
|
$487,037 | $0 | 28 Feb 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
85,584
|
$417,650 | — | 31 Mar 2025 | |
| Qiming U.S. Ventures Management, LLC |
13F
|
Company |
1.1%
|
82,871
|
$404,410 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
82,614
|
$403,157 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.91%
|
67,564
|
$329,794 | — | 31 Mar 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.91%
|
67,511
|
$329,454 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.87%
|
64,509
|
$314,804 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
41,000
|
$200,080 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.43%
|
32,310
|
$157,673 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.43%
|
31,870
|
$155,526 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
31,380
|
$153,134 | — | 31 Mar 2025 | |
| RBF Capital, LLC |
13F
|
Company |
0.38%
|
28,253
|
$137,875 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
28,178
|
$137,509 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.34%
|
25,555
|
$124,708 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
21,093
|
$102,934 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
20,900
|
$101,992 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.27%
|
20,299
|
$99,059 | — | 31 Mar 2025 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.21%
|
15,805
|
$77,128 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.19%
|
14,305
|
$69,808 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
13,940
|
$68,027 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
7,211
|
$35,190 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.08%
|
5,703
|
$27,831 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
2,040
|
$9,955 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
172
|
$839 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
166
|
$810 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
96
|
$468 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
100
|
$402 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
51
|
$249 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
4
|
$20 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1
|
$5 | — | 31 Mar 2025 | |
| Nicholas Michael Mordwinkin |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
275,000
|
— | — | 07 Jan 2024 | |
| Noreen Henig |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
220,000
|
— | — | 24 Jul 2023 | |
| Christopher J. Kirk |
3/4/5
|
CEO, Director |
—
class O/S missing
|
120,000
|
— | — | 09 Jan 2025 | |
| Jason Dinges |
3/4/5
|
Director |
—
class O/S missing
|
26,000
|
— | — | 28 Jun 2021 | |
| Jean-Pierre Sommadossi |
3/4/5
|
Director |
—
class O/S missing
|
26,000
|
— | — | 28 Jun 2021 | |
| Marc Belsky |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
12,000
|
— | — | 27 Mar 2025 | |
| Courtney Wallace |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
— | — | 18 Jun 2025 |
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock (KZR) as of Q2 2025
As of 30 Jun 2025,
Kezar Life Sciences, Inc. - Common Stock (KZR) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,474,800 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BML Capital Management, LLC, Avidity Partners Management LP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Stonepine Capital Management, LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, and Peapod Lane Capital LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
40
Q2 2025 holders
38
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.